A state court jury awarded Alabama $215 million Thursday in its Medicaid drug price fraud suit against AstraZeneca Pharmaceuticals.

The circuit court jury said the subsidiary of Britain’s AstraZeneca must pay $40 million in compensatory damages and $175 million in punitive damages.